AnalystsTimur IvannikovTimur Ivannikov's Stock Forecasts
AnalystsTimur Ivannikov
Sectors:
Industries:
Analyst Ranking
Bottom 16%
#4219 out of 4986 analysts
Average Return
-9.11%
Win Rate
50%4 out of 8
Risk vs Reward
Poor
Good
Timur Ivannikov's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Astria Therapeutics IncATXS | +58.69% | $3.97 | $6.30 | 2025-05-14 - 2025-08-19 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +46.36% | $44.74 | $65.48 | 2022-03-01 - 2023-02-28 | Strong Buy |
Pharvaris NvPHVS | +44.74% | $16.07 | $23.26 | 2025-05-14 - 2025-08-19 | Strong Buy |
Rocket Pharmaceuticals IncRCKT | +13.33% | $16.66 | $18.88 | 2022-07-08 - 2023-07-07 | Buy |
Timur Ivannikov Analyst Color
Get additional color on Timur Ivannikov's coverage of popular stocks
Timur Ivannikov's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $8.00 | +294.09% | Reiterates | 2 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $25.00 | +7.48% | Maintains | 3 months ago |
Astria Therapeutics IncATXS | 1 | Strong Buy | $47.00 | +646.03% | Reiterates | 3 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Gossamer Bio IncGOSS | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 3 years ago |
Apellis Pharmaceuticals IncAPLS | 1 | Strong Buy | $114.00 | N/A | Maintains | 3 years ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $285.00 | N/A | Maintains | 4 years ago |
Neximmune IncNEXI | 1 | Buy | $750.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.